Enterprise Software Streamlining Addiction Treatment

Raised $2,500,000

8.0% Series B Convertible Preferred Stock

Pre-Money Valuation $12,000,000

  • All-in-one-software solution consolidating electronic Health Records (EHR), Patient Management (PM), and Revenue Cycle Management (RCM) for addiction treatment and behavioral health centers. Website.

  • Andrea Barthwell, MD, DFASAM, former Deputy Drug Czar under George W. Bush, has joined as a Senior Advisor and Strategist.

  • 65.0% revenue growth in 2021, exceeding long-term growth of 61.0% per year since 2019. Growth accomplished with a single-person sales team, a significant backlog of won contracts waiting to be implemented, and a robust pipeline awaiting conversion.

AZZLY, Inc., (the “Issuer” or “The Company”) issued $2,500,000 in convertible preferred stock (the “Securities” or “Series B Preferred”) for marketing efforts, technological development, and working capital.

By registering with Carofin, Members have access to more extensive due diligence materials, additional private investment opportunities, and can proceed with making an investment.